Machine learning identifies prognosticators of intracranial metastatic disease in patients with breast or lung cancer
Machine learning models accurately predict which cancer survivors are at highest risk for brain spread, enabling smarter monitoring strategies.
This study developed interpretable ML competing-risk models achieving high discrimination (C-index 0.95/0.88 for breast/lung) for brain metastasis risk stratification, outperforming baseline strategies in decision-curve analysis. Identifying patients at highest brain metastasis risk could enable targeted surveillance protocols that catch intracranial spread earlier in breast and lung cancer survivors.
What the study was
- Study design
- Retrospective cohort; interpretable ML competing-risk survival models
- Population
- Breast or lung cancer patients at risk for intracranial metastatic disease; Ontario population-based dataset
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Communications Medicine
Why it surfaced
Interpretable ML with high C-index for brain met prediction in breast/lung cancer; population-based cohort; publication in Communications Medicine.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.